Journal of Pharmacy and Pharmaceutical Sciences

Papers
(The median citation count of Journal of Pharmacy and Pharmaceutical Sciences is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Simulation of Remdesivir Pharmacokinetics and Its Drug Interactions60
A new method for investigating bioequivalence of inhaled formulations: A pilot study on salbutamol46
Effect of Oregon grape root extracts on P-glycoprotein mediated transport in in vitro cell lines43
Should Codeine Still be Considered a WHO Essential Medicine?40
Sigmoid Sinus Thrombosis Followed by Splenic Infarction Due to Imatinib Therapy in a Patient with Gastrointestinal Stromal Tumor; Hematological Side Effects of Imatinib34
Development of a Rat Sandwich-Cultured Hepatocytes Model Expressing Functional Human Organic Anion Transporting Polypeptide (OATP) 1B3: A Potential Screening Tool for Liver-Targeting Compounds34
A Survey of the Criteria Used for the Selection of Alternative Comparator Products by Participating Regulators and Organizations of the International Pharmaceutical Regulators Programme21
Microneedles as an Alternative Strategy for Drug Delivery20
Analysis of Prednisolone-Induced Osteoporosis Using the Japanese Adverse Drug Event Report Database19
Tenapanor: A new treatment option for hyperphosphatemia in end stage kidney disease15
Grading pharmacists’ risk of complaints to a regulator: A retrospective cohort study15
Weighing in on the role of brown adipose tissue for treatment of obesity15
Comparing broad and narrow phenotype algorithms: differences in performance characteristics and immortal time incurred13
Gastrointestinal perforation associated with novel antineoplastic agents: A real-world study based on the FDA Adverse Event Reporting System11
Drug-disease interaction: Clinical consequences of inflammation on drugs action and disposition11
High-quality reports and their characteristics in the Japanese Adverse Drug Event Report database (JADER)11
The mechanism of Leonuri Herba in improving polycystic ovary syndrome was analyzed based on network pharmacology and molecular docking11
Remdesivir-induced conduction abnormalities: A molecular model-based explanation11
The bioequivalence study design recommendations for immediate-release solid oral dosage forms in the international pharmaceutical regulators programme participating regulators and organisations: diffe10
The role of CYP2C9*2, CYP2C9*3 and VKORC1-1639 variants on the susceptibility of upper gastrointestinal bleeding: A full case-control study10
Evaluating the Effects of Agomelatine on Polysomnography Parameters in Patients with Obstructive Sleep Apnea.10
Factors Influencing 1st and 2nd Generation Drug-Eluting Stent Performance: Understanding the Basic Pharmaceutical Drug-in-Polymer Formulation Factors Contributing to Stent Thrombosis Do We Really Need10
Monkeypox: Virology, Pathophysiology, Clinical Characteristics, Epidemiology, Vaccines, Diagnosis, and Treatments9
Therapeutic update on oral potassium exchange resin use in chronic kidney disease patients: a systematic review of randomized controlled clinical trials9
The Effect of HIV/AIDS Infection on the Clinical Outcomes of COVID-19: A Meta-Analysis7
A Review of Electronic Cigarettes and Liquid Nicotine Poisoning Exposure Cases in the United States7
Corrigendum: Applications of exhaled breath condensate analysis for drug monitoring and bioequivalence study of inhaled drugs7
Effectiveness and safety evaluation of thrice weekly double strength vs daily single strength trimethoprim-sulfamethoxazole for prophylaxis of pneumocystis jirovecii pneumonia after kidney transplanta7
What a pain in the … back: a review of current treatment options with a focus on naproxen sodium7
A big leap in prescription drug promotion in Canada6
Integration of real-world evidence from different data sources in health technology assessment6
Requirements for Additional Strength Biowaivers for Modified Release Solid Oral Dosage Forms in International Pharmaceutical Regulators Programme Participating Regulators and Organisations: Difference6
Data collection within patient support programs in Canada and implications for real-world evidence generation: the authors’ perspective6
Metabolic flux in macrophages in obesity and type-2 diabetes5
Intraluminal Behavior of Various Transporter Substrates in the Rat Gastrointestinal Tract5
Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy5
Angiotensin-Converting Enzyme Inhibitor Induced Cough in Chinese Patients: a Systematic Review and Meta-analysis5
The 2022 Canadian Society for Pharmaceutical Sciences/Canadian Chapter of Controlled Release Society Annual Symposium was held virtually from June 1-2, 2022.5
Impact of hyperuricemia on long-term clinical outcomes of renal transplant recipients: a systematic review and meta-analysis5
Research progress on vesicle cycle and neurological disorders5
Pyrrole as an Important Scaffold of Anticancer Drugs: Recent Advances5
Changes in Rosuvastatin Pharmacokinetics During Postnatal Ontogenesis in Rats5
KNIME-based Analysis of Off-Target Effect of Drugs Related to The Molecular 2D Fingerprint5
Effect of Concomitant Drug Use on the Onset and Exacerbation of Diabetes Mellitus in Everolimus-Treated Cancer5
Safety and Efficacy of Remdesivir for the Treatment of COVID-19: A Systematic Review and Meta-Analysis4
Recent Advances in Oral Mucoadhesive Drug Delivery4
Lipoprotein lipase as a target for obesity/diabetes related cardiovascular disease4
Network pharmacology and molecular docking reveal the immunomodulatory mechanism of rhubarb peony decoction for the treatment of ulcerative colitis and irritable bowel syndrome4
Treatment of Hypertriglyceridemia with Aggressive Continuous Intravenous Insulin4
A Survey of the Regulatory Requirements for the Waiver of In Vivo Bioequivalence Studies of Generic Products in Certain Dosage Forms by Participating Regulators and Organisations of the International 3
Corrigendum: Recent progress of polymeric microneedle-assisted long-acting transdermal drug delivery3
Effects of compound-326, a selective delta-5 desaturase inhibitor, in ApoE knockout mice with two different protocols for atherosclerosis development3
Development and validation of an LC-MS/MS method for ruxolitinib quantification: advancing personalized therapy in hematologic malignancies3
A Legislative/Legal History of Prescription Drug Advertising and Promotion Regulation3
Applications of Exhaled Breath Condensate Analysis for Drug Monitoring and Bioequivalence Study of Inhaled Drugs3
Development of modular polymeric nanoparticles for drug delivery using amine reactive chemistry3
Erratum to 'Piecing Together Human Adult Comparative Pharmacokinetic Trials and Rodent Studies: What Happens to Drug Clearance in Obesity?'3
Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India2
Abstracts of poster presentations at the 2021 virtual annual of the Canadian Society for Pharmaceutical Sciences.2
Pharmacometabolomics of sulfonylureas in patients with type 2 diabetes: a cross-sectional study2
Solid Lipid Nanoparticles: An Approach to Improve Oral Drug Delivery2
Genetics, pharmacotherapy, and dietary interventions in childhood obesity2
Evaluation of the rational prescription of linezolid, the prevalence of thrombocytopenia and major drug interactions in patients with cardiovascular diseases: are there any cautions?2
Lopinavir/Ritonavir for COVID-19: a Systematic Review and Meta-Analysis2
Short Acting Beta Agonist Use Associated with Increased Mortality and Morbidity in Asthma Patients: A Systematic Review and Meta-Analysis2
Efficacy and Safety of Anticoagulants for COVID-19 Patients in the Intensive Care Unit: A Systematic Review and Meta-Analysis2
A Nanoparticle Delivery of Plasmid Encoding Hepatocyte Growth Factor for Gene Therapy of Silicosis in Mice2
The Lymphatic System: A Sometimes-Forgotten Compartment in Pharmaceutical Sciences1
The role of branched-chain amino acids and their downstream metabolites in mediating insulin resistance1
Forkhead box O1 transcription factor; a therapeutic target for diabetic cardiomyopathy1
Development of a dry powder formulation for pulmonary delivery of azithromycin-loaded nanoparticles1
Preparation, solubility, and anti-inflammatory effects of a complex of diphenylcyclopropenone/β-cyclodextrin derivatives as the treatment of alopecia areata1
Pharmacokinetics of α-Pyrrolidinovalerophenone in Male Rats with and without Vaccination with an α-Pyrrolidinovalerophenone Vaccine1
Obesity management for the treatment of type 2 diabetes: emerging evidence and therapeutic approaches1
Association Between Vitamin D Levels and Inflammatory Markers in COVID-19 Patients: A Meta-Analysis of Observational Studies1
The role of acetylation in obesity-induced cardiac metabolic alterations1
Safety and efficacy of phosphodiesterase-5 (PDE-5) inhibitors in fetal growth restriction: a systematic literature review and meta-analysis1
Post-Marketing Safety of Vemurafenib: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System1
Naproxen for Post-Operative Pain1
Evaluation of Clinical Outcomes of Intravenous Drug Use-Related Infective Endocarditis in Buprenorphine-Treated Patients1
Evaluating Nicotine Abstinence, Smoking Cessation, Reduction and its Relapsed Among Electronic Cigarettes Single and Dual Malaysian Users: A One Year Observational Study1
Progress and Prospects of Research Ideas and Methods in the Network Pharmacology of Traditional Chinese Medicine1
Effects of Vitamin D Serum Level on Morbidity and Mortality in Patients with COVID-19: A Systematic Review and Meta-Analysis1
Design and evaluation of albumin nanoparticles for the delivery of a novel β-tubulin polymerization inhibitor1
Professor Endrenyi’s Legacy: An Evaluation of the Regulatory Requirement “Fixed Effects, Rather Than Random Effects, Should Be Used for All Terms”1
Film dressings from Thai mango seed kernel extracts versus nanocrystalline silver dressings in antibacterial properties1
Determinants of disease acceptance in renal transplantation patients assessed with the application of Acceptance Illness Scale (AIS)1
Investigating the effect of prescribing status and patient characteristics on the therapeutic outcomes in patients with diabetes using a leftover drug adjustment protocol1
Clinical Outcomes of COVID-19 Patients Treated with Convalescent Plasma or Remdesivir Alone and in Combination at a Community Hospital in California’s Central Valley1
0.076502799987793